Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivaracetam for Neuropathic Pain in SCI
NCT04379011Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Feb 2021
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of brivaracetam in neuropathic pain (2 arms), sponsored by University of Minnesota. Primary endpoints: Brief Pain Inventory, Worst Pain at 3 months, Brief Pain Inventory, Least Pain at 3 months and 2 more. Started Feb 2021; status: completed.
02
Drugs
brivaracetam
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT04379011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04379011.